CGL
MET icon

Clarius Group LLC’s MetLife MET Stock Holding History

Clarius Group LLC’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$221K Sell
2,799
-59
-2% -$4.67K 0.01% 357
2025
Q3 		$235K Sell
2,858
-2,396
-46% -$189K 0.01% 350
2025
Q2 		$423K Sell
5,254
-304
-5% -$23.5K 0.02% 284
2025
Q1 		$446K Sell
5,558
-47
-0.8% -$3.91K 0.03% 263
2024
Q4 		$459K Buy
5,605
+54
+1% +$4.49K 0.03% 234
2024
Q3 		$457K Sell
5,551
-137
-2% -$10.2K 0.03% 232
2024
Q2 		$399K Sell
5,688
-344
-6% -$24.6K 0.03% 254
2024
Q1 		$447K Sell
6,032
-289
-5% -$20.1K 0.03% 243
2023
Q4 		$418K Buy
6,321
+117
+2% +$7.32K 0.03% 270
2023
Q3 		$390K Sell
6,204
-2,464
-28% -$153K 0.04% 265
2023
Q2 		$490K Sell
8,668
-1,197
-12% -$66.4K 0.04% 268
2023
Q1 		$572K Sell
9,865
-280
-3% -$18.9K 0.05% 224
2022
Q4 		$734K Buy
10,145
+66
+0.7% +$4.73K 0.07% 176
2022
Q3 		$613K Buy
10,079
+215
+2% +$13.7K 0.06% 186
2022
Q2 		$619K Buy
9,864
+586
+6% +$38.8K 0.06% 188
2022
Q1 		$580K Hold
9,278
– – 0.05% 214
2021
Q4 		$580K Buy
9,278
+135
+1% +$8.47K 0.05% 214
2021
Q3 		$564K Buy
9,143
+312
+4% +$18.8K 0.05% 193
2021
Q2 		$529K Buy
8,831
+43
+0.5% +$2.73K 0.05% 200
2021
Q1 		$534K Buy
8,788
+1,266
+17% +$69.9K 0.05% 179
2020
Q4 		$353K Buy
7,522
+618
+9% +$26.8K 0.04% 228
2020
Q3 		$257K Sell
6,904
-749
-10% -$28.4K 0.03% 237
2020
Q2 		$279K Sell
7,653
-2,673
-26% -$93K 0.04% 221
2020
Q1 		$316K Buy
10,326
+3,673
+55% +$163K 0.06% 173
2019
Q4 		$345K Sell
6,653
-20
-0.3% -$965 0.05% 179
2019
Q3 		$315K Buy
6,673
+187
+3% +$8.92K 0.06% 179
2019
Q2 		$322K Buy
6,486
+544
+9% +$25.6K 0.06% 157
2019
Q1 		$253K Buy
+5,942
New +$263K 0.06% 166

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clarius Group LLC's MET Position: Q4 2025 in Review

Clarius Group LLC reduced its MetLife (MET) stake by 2.1% in Q4 2025, selling an estimated $4.67K and leaving 2,799 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #357.

Clarius Group LLC first reported a position in MET in Q1 2019 and has held it in 28 quarters since. The position peaked at $734K in Q4 2022. 1,440 funds tracked by Wall St. Rank hold MET as of Q4 2025.

  • Clarius Group LLC held 2,799 shares of MetLife worth $221K as of Q4 2025.
  • Clarius Group LLC sold 59 MetLife shares in Q4 2025, an estimated $4.67K.
  • MetLife made up 0.01% of Clarius Group LLC's portfolio in Q4 2025, its #357 holding.
  • Clarius Group LLC first reported a position in MetLife in Q1 2019 and has held it in 28 quarters since.
  • Clarius Group LLC's MetLife position peaked at $734K in Q4 2022.
  • 1,440 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.